Presentation and outcome amongst older Singaporeans living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): does age alone drive excess mortality?
- Author:
Paul J HUGGAN
1
;
Rui Min FOO
;
Dariusz OLSZYNA
;
Nicholas S CHEW
;
Nares SMITASEN
;
Amartya MUKHOPADHYAY
;
Sophia ARCHULETA
Author Information
- Publication Type:Journal Article
- MeSH: Acquired Immunodeficiency Syndrome; mortality; Adolescent; Adult; Age Factors; Aged; Female; HIV Infections; mortality; HIV Long-Term Survivors; Humans; Male; Middle Aged; Models, Theoretical; Mortality; trends; Prognosis; Retrospective Studies; Singapore; epidemiology; Social Class; Young Adult
- From:Annals of the Academy of Medicine, Singapore 2012;41(12):581-586
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTIONThere is little detailed information on human immunodeficiency virus (HIV) amongst older adults in Singapore.
MATERIALS AND METHODSA retrospective study of 121 consecutive referrals of patients presenting for HIV care was conducted. Demographic, clinical and laboratory variables were collected. A prognostic model derived from the North American Veterans' Affairs Cohort Study (VACS) was used to estimate prognosis.
RESULTSThe median age at presentation was 43 (range, 18 to 76). Thirty-eight patients (31%) were aged 50 or older and 106 patients (88%) were male. Older patients were more likely to be of Chinese ethnicity (P = 0.035), married (P = 0.0001), unemployed or retired (P = 0.0001), and to have acquired their infection heterosexually (P = 0.0002). The majority of patients in both groups were symptomatic at presentation. Eighty-one (67%) had CD4 counts less than 200 at baseline with no observable differences in HIV ribonucleic acid (RNA) or clinical stage based on age. Non-Acquired Immunodeficiency Syndrome (AIDS) morbidity was observed more frequently amongst older patients. The estimated prognosis of patients differed significantly based on age. Using the VACS Index and comparing younger patients with those aged 50 and above, mean 5 year mortality estimates were 25% and 50% respectively (P <0.001). A trend towards earlier antiretroviral therapy was noted amongst older patients (P = 0.067) driven mainly by fewer financial difficulties reported as barriers to treatment.
CONCLUSIONOlder patients form a high proportion of newly diagnosed HIV/AIDS cases and present with more non-AIDS morbidity. This confers a poor prognosis despite comparable findings with younger patients in terms of clinical stage, AIDS-defining illness, CD4 count and HIV viral load.